Company Profile

Antex Biologics Inc (AKA: Antex Pharma Inc~Biocarb~MicroCarb Inc)
Profile last edited on: 7/30/2010      CAGE:       UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
1991
First Award
1994
Latest Award
2001
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

300 Professional Drive
Gaithersburg, MD 20879
   N/A
   N/A
   www.antexbiologics.com
Location: Single
Congr. District: 06
County: Montgomery

Public Profile

After Antex filed for bankruptcy in March 2003, effective May 2003, the assets of Antex Biologics Inc. and its wholly owned subsiduary AntexPharma Inc. were acquired by BioPort Corporation. The firm is a biopharmaceutical company committed to developing and marketing new products to prevent and treat infections and related diseases. Anthrax vaccine-maker BioPort of Lansing, MI settled on Frederick for its new manufacturing plant and warehouse and renamed the firm Advanced BioSolutions. The following year (2004) Emergent BioSolutions was founded by BioPort Corporation and, through corporate restructuring, became the parent company of BioPort Corporation (now Emergent BioDefense Operations Lansing Inc.) and Antex Biologics Inc. (now Emergent Product Development Gaithersburg Inc.) Emergent BioSolutions (NYSE:EBS) is a multinational biopharmaceutical company headquartered in Rockville, Maryland. Emergent's portfolio of products in development includes preventive and therapeutic products for anthrax and botulism, two top priority ("Category A") bioterrorism agents. The company also has vaccines for typhoid, hepatitis B, and group B streptococcus in development.[1]

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
25-49
Revenue Range
2.5M-5M
VC funded?
Yes
Public/Private
Publicly Traded
Stock Info
OTC : ANXB
IP Holdings
25-49

Awards Distribution by Agency

Key People / Management

  V M Esposito -- President

  Steve M Frey

  Washington J Jackson

  John Pace

  Theresa M Stevens

  Richard Walker

Company News

There are no news available.